Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
Clinical trial NCT05936567 · COMPLETED
Trial details
- NCT number
- NCT05936567
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2025-02-28
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.